0.62
+0.81%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Concord Healthcare Group Co
Its shares trade on HKEX under the ticker 2453.HK. It has been listed since 9 January 2024. In the fiscal year to 31 December 2024, it reported revenue of CN¥388.3m and a net loss of CN¥443.2m. At that date it held total assets of CN¥5.91bn and shareholders' equity of CN¥1.65bn.
Concord Healthcare Group Co Ltd is a CN-based company operating in industry. The company is headquartered in Beijing, Beijing. The company went IPO on 2024-01-09. Concord Healthcare Group Co Ltd is a China-based company principally engaged in the provision of oncology healthcare services. The firm serves both cancer patients through its self-owned medical institutions and third-party medical institutions through its medical equipment, software and related services. The firm owns its self-owned medical institutions in operation located in Guangzhou, Shanghai and Datong, including cancer hospitals, outpatient centers or clinic and imaging diagnosis centers, as well as Internet hospital.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 9 Jan 2024
- Website
- concordmedical.com ↗
Leadership
Pay as last reported
- Dr. Jianyu YangExecutive Chairman of the Board, since 2008CN¥1.3m
- Ms. Xiao FuPresident, General Manager, Executive Director, since 2009CN¥1.9m
- Mr. Lei WangNon-Executive Vice Chairman of the Board
- Ms. Ying ChangChief Financial Officer
- Mr. Liang ChangVice President, Executive Director, since 2015CN¥667,000
- Ms. Wing Nga HoJoint Company Secretary
- Mr. Lichen PanJoint Company Secretary
- Mr. Hongzhang ChenNon-Executive Director
- Mr. Botao ShiNon-Executive Director, since 2015
- Ms. Xuemei LiNon-Executive Independent Director
- Mr. Kwok Yin NgNon-Executive Independent Director
- Mr. Yansheng SunNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Concord Healthcare Group operates self-owned medical institutions in Guangzhou, Shanghai, and Datong.
- The company provides oncology healthcare services through its own hospitals and third-party institutions.
- Concord Healthcare Group offers medical equipment, software, and related services to third-party medical institutions.
Weaknesses
- The company's self-owned medical institutions are limited to Guangzhou, Shanghai, and Datong.
- Concord Healthcare Group's IPO was on 9 January 2024, a recent listing.
- The firm's services are primarily focused on oncology healthcare in China.
Opportunities
- Expanding oncology healthcare services to more cities in China could increase market reach.
- The growing demand for cancer treatment in China presents a significant opportunity.
- Concord Healthcare Group can leverage its Internet hospital to expand telemedicine services.
Threats
- Competition from other healthcare providers in China's oncology sector is increasing.
- Regulatory changes in China's healthcare industry could impact operations.
- Economic downturns may reduce patient access to specialized cancer care.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.